A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
<h4>Background</h4>Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public health as demonstrated by its high associated mortality rate (23-90%) and recent emergence in West Africa for the first time. Although a recombinant vesicular stomatitis virus (rVSV)-based v...
Saved in:
Main Authors: | Courtney Woolsey (Author), Robert W Cross (Author), Krystle N Agans (Author), Viktoriya Borisevich (Author), Daniel J Deer (Author), Joan B Geisbert (Author), Cheryl Gerardi (Author), Theresa E Latham (Author), Karla A Fenton (Author), Michael A Egan (Author), John H Eldridge (Author), Thomas W Geisbert (Author), Demetrius Matassov (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013) -
Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys.
by: Robert W Cross, et al.
Published: (2020) -
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
by: Chad E Mire, et al.
Published: (2012) -
Transgenic nonhuman primates for neurodegenerative diseases
by: Chan Anthony WS
Published: (2004) -
Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus.
by: Sara Garamszegi, et al.
Published: (2014)